Watch NAMS. Know when insiders buy.
One email the day a filing lands. Free.
NAMS
NewAmsterdam Pharma Co N.V.
21.49
−0.01 −0.05%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
33
FLAG · insiders 30, shorts 36
Insiders, 90 days
−$4.4M
net selling · 1 buy, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.6BP/E —DIV YIELD —FCF YIELD -5.59%REV TTM $7.1M −88.9%NET INCOME −$259.5MNET CASH —52W 19.83 – 41.45NEXT EARNINGS Nov 4 EST.SEC XBRL · TTM TO Invalid Date
Insider trading
−$4.4M
Net, 90 days
1 / 3
Buys / sells, 90 days
1
Distinct buyers
$227K
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 30 | Oct 2 | Kastelein Johannes Jacob Pieter · Chief Scientific Officer | Sell | 50,246 | $25.03 | $1.3M |
| Sep 14 | Sep 15 | Davidson Michael H. · Chief Executive Officer | Buy | 10,000 | $22.65 | $227K |
| Sep 4 | Sep 9 | Smither John W · Director | Sell | 1,600 | $25.32 | $41K |
| Aug 24 | Aug 25 | Kastelein Johannes Jacob Pieter · Chief Scientific Officer | Sell | 125,000 | $26.91 | $3.4M |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.